Real-time enrollment status for this dravet syndrome clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:53 PM UTC
| NCT Number | NCT06872125 |
| Recruiting Status | Recruiting |
| Condition | Dravet Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 170 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Stoke Therapeutics, Inc |
| Last Updated on CT.gov | August 24, 2026 (Aug 24, 2026) |
As of October 17, 2026: Clinical trial NCT06872125 is currently recruiting participants. This phase3 study for dravet syndrome is actively seeking new participants at 28 locations across the United States. The study is sponsored by Stoke Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06872125 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06872125 was last updated Aug 24, 2026 (August 24, 2026). HelloStudys verifies this status automatically.